Cite
HARVARD Citation
Kimmoun, A. et al. (2019). Safety, Tolerability and efficacy of Rapid Optimization, helped by NT‐proBNP and GDF‐15, of Heart Failure therapies (STRONG‐HF): rationale and design for a multicentre, randomized, parallel‐group study. European journal of heart failure. pp. 1459-1467. [Online].